54 related articles for article (PubMed ID: 25461314)
21. Novel hybrids derived from aspirin and chalcones potently suppress colorectal cancer
Lu S; Obianom ON; Ai Y
Medchemcomm; 2018 Oct; 9(10):1722-1732. PubMed ID: 30429977
[TBL] [Abstract][Full Text] [Related]
22. Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine.
Qin JJ; Li X; Hunt C; Wang W; Wang H; Zhang R
Genes Dis; 2018 Sep; 5(3):204-219. PubMed ID: 30320185
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms underlying the antiproliferative effects of a series of quinoxaline-derived chalcones.
Mielcke TR; Muradás TC; Filippi-Chiela EC; Amaral MEA; Kist LW; Bogo MR; Mascarello A; Neuenfeldt PD; Nunes RJ; Campos MM
Sci Rep; 2017 Nov; 7(1):15850. PubMed ID: 29158524
[TBL] [Abstract][Full Text] [Related]
24. Chalcone: A Privileged Structure in Medicinal Chemistry.
Zhuang C; Zhang W; Sheng C; Zhang W; Xing C; Miao Z
Chem Rev; 2017 Jun; 117(12):7762-7810. PubMed ID: 28488435
[TBL] [Abstract][Full Text] [Related]
25. Novel chalcone derivatives as hypoxia-inducible factor (HIF)-1 inhibitor: synthesis, anti-invasive and anti-angiogenic properties.
Wang L; Chen G; Lu X; Wang S; Han S; Li Y; Ping G; Jiang X; Li H; Yang J; Wu C
Eur J Med Chem; 2015 Jan; 89():88-97. PubMed ID: 25462229
[TBL] [Abstract][Full Text] [Related]
26. Design, Synthesis, and
Alimujiang Y; Maimaiti A; Ablise M; Yang Z; Liu Z; Wang Y; Mutalipu Z; Yan T
Anticancer Agents Med Chem; 2024; 24(6):423-435. PubMed ID: 38204258
[TBL] [Abstract][Full Text] [Related]
27. Activity of novel quinoxaline-derived chalcones on in vitro glioma cell proliferation.
Mielcke TR; Mascarello A; Filippi-Chiela E; Zanin RF; Lenz G; Leal PC; Chiaradia LD; Yunes RA; Nunes RJ; Battastini AM; Morrone FB; Campos MM
Eur J Med Chem; 2012 Feb; 48():255-64. PubMed ID: 22209415
[TBL] [Abstract][Full Text] [Related]
28. Trans-4-lodo,4'-boranyl-chalcone induces antitumor activity against malignant glioma cell lines in vitro and in vivo.
Sasayama T; Tanaka K; Mizukawa K; Kawamura A; Kondoh T; Hosoda K; Kohmura E
J Neurooncol; 2007 Nov; 85(2):123-32. PubMed ID: 17530176
[TBL] [Abstract][Full Text] [Related]
29. Oligosaccharide G19 inhibits U-87 MG human glioma cells growth in vitro and in vivo by targeting epidermal growth factor (EGF) and activating p53/p21 signaling.
Liu H; Zhou L; Shi S; Wang Y; Ni X; Xiao F; Wang S; Li P; Ding K
Glycobiology; 2014 Aug; 24(8):748-65. PubMed ID: 24799378
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo anti-glioma activity of a chalcone-quinoxaline hybrid.
Loch-Neckel G; Bicca MA; Leal PC; Mascarello A; Siqueira JM; Calixto JB
Eur J Med Chem; 2015 Jan; 90():93-100. PubMed ID: 25461314
[TBL] [Abstract][Full Text] [Related]
31. Chalcone Derivatives: Role in Anticancer Therapy.
Ouyang Y; Li J; Chen X; Fu X; Sun S; Wu Q
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208562
[TBL] [Abstract][Full Text] [Related]
32. Current scenario of chalcone hybrids with antibreast cancer therapeutic applications.
Wang H; Zhu J; Zhang Q; Tang J; Huang X
Arch Pharm (Weinheim); 2024 May; 357(5):e2300640. PubMed ID: 38227398
[TBL] [Abstract][Full Text] [Related]
33. Quinoxaline derivatives: Recent discoveries and development strategies towards anticancer agents.
Montero V; Montana M; Carré M; Vanelle P
Eur J Med Chem; 2024 May; 271():116360. PubMed ID: 38614060
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
